DialyseArchiv
Clinic- and home-based renal rehabilitation improves spKt/V and uremic syndrome in hemodialysis patients: a case reportDialyse 3 min.
Kidney failure is considered one of the leading cause of morbidity and mortality worldwide. Hemodialysis (HD) is the most common modality of renal replacement therapy for end-stage kidney disease (ESKD) patients, and its rate of uptake has been increasing in China [1]. However, the health-related quality...
A clinical study of efficacy and safety of the Carry Life UF system in continuous ambulatory peritoneal dialysis patients: protocol for a prospective, multicenter, randomized, crossover studyDialyse 8 min.
Achieving adequate peritoneal ultrafiltration (UF) and sodium removal is a challenge in peritoneal dialysis (PD). Despite volume management being an important component of PD prescription [1, 2], volume overload remains a common problem for PD patients with a prevalence ranging from 56 to 72% [3, 4–5]....
Real-world use of difelikefalin in hemodialysis patients at a large dialysis organization in the United States: a retrospective database studyDialyse 5 min.
Chronic kidney disease–associated pruritus (CKD-aP), previously referred to as uremic pruritus, is itching due to kidney disease that can vary in clinical presentation from mild to severe and can affect patient quality of life and survival [1, 2–3]. CKD-aP can be recurrent and sometimes persistent...
Association of the remnant cholesterol to high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patientsDialyse 5 min.
End-stage renal illness severely affects health care systems and is prevalent worldwide [1]. One of the primary options for end-stage renal illness, which affects approximately 11% of dialysis patients overall, is continuous ambulatory peritoneal dialysis (CAPD) [2]. Cardiovascular complications represent...
